W o r l d o f R e p r o d u c t i v e B i o l o g y Adaptive Immunity Regulates Mammary Gland Development
Charlotte Schubert, Ph.D., Science Writer
The mammary glands of mice develop during puberty in sync with signals from the adaptive immune system [1] . This new finding adds to the repertoire of signals-including innate immune factors-that control mammary gland development, and has implications for understanding immune function in breast cancer.
Hormones initiate mammary gland development during puberty and regulate the cyclical expansion and regression of the gland with each estrous cycle. A variety of signals between the epithelial cells in the developing gland and the extracellular and stromal milieu, including immune cells, also play a role. Previous studies have shown that various innate immune cells and signals positively regulate expansion of the mammary ducts during puberty. Vicki Plaks et al. now find a role for adaptive immune cells in inhibiting this expansion.
The researchers found that mammary antigen-presenting cells (APCs) are closely associated with the mammary epithelium ( Fig. 1 )-these cells have characteristics of dendritic-like cells, which have long extensions, and express the CD11c marker. In mice, and in an ex vivo threedimensional organotypic culture system, the researchers found that these APCs interact with CD-4 positive T helper (Th) 1 cells. This interaction locally quashes development of the mammary ducts via interferon-c, which is produced by the Th1 cells.
The findings flesh out a model of mammary gland development that resembles wound healing, in which APCs communicate with other immune cells to regulate tissue remodeling. In the mammary gland, it seems as if the Th2-type cells induce morphogenesis, whereas the Th1-type cells suppress it.
Further studies will help assess how these positive and negative regulators interact during normal and aberrant development in breast cancer. Consistent with the new study, previous research has suggested that breast cancer progression is a Th2-mediated process, and that Th1-type cells and interferon-c can counteract tumorigenesis.
